GENSCRIPT BIO (01548) announced that on September 19, 2025, the company granted a total of 775,000 share awards to employee grantees and one director of the company, subject to acceptance and compliance with the terms and conditions of the 2019 Restricted Share Unit Plan.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.